Location History:
- Mt. Laurel, NJ (US) (2008 - 2011)
- Albuquerque, NM (US) (2012 - 2014)
Company Filing History:
Years Active: 2008-2014
Title: Loraine V Upham: Innovator in Peptide Applications for Diabetes Treatment
Introduction
Loraine V Upham is a notable inventor based in Albuquerque, NM, who has made significant contributions to the field of medical science through her innovative work on peptides. With a total of eight patents to her name, Loraine's groundbreaking research focuses on methods to treat type 1 and type 2 diabetes, as well as various metabolic disorders.
Latest Patents
Loraine's latest patents include the development of Human proIslet Peptides (HIP) and their analogs and derivatives, which are derived from or homologous to the human REG3A protein found on chromosome 2p12. These peptides have been shown to induce islet neogenesis from endogenous pancreatic progenitor cells. The application of these peptides extends beyond diabetes, addressing conditions related to aberrant glucose, carbohydrate, and lipid metabolism, including insulin resistance, obesity, polycystic ovarian syndrome, and metabolic syndrome. Additionally, her patents involve compositions and methods for utilizing proislet peptides that demonstrate enhanced stability and efficacy in treating pathologies associated with impaired pancreatic function.
Career Highlights
Throughout her career, Loraine has worked with companies such as Curedm Group Holdings, LLC and Curedm, Inc., where she focused on pioneering research in peptide therapeutics. Her contributions have helped shape the landscape of diabetes treatment and have the potential to improve the quality of life for countless individuals.
Collaborations
Loraine has collaborated with esteemed colleagues, including Claresa S Levetan and Victor M Garsky. These partnerships have fostered a collaborative environment that encourages innovative solutions to complex medical challenges, further solidifying her role as a leader in her field.
Conclusion
Loraine V Upham's work exemplifies the spirit of innovation in the realm of medical science. Her advancements in peptide research not only highlight her expertise as an inventor but also showcase the potential for her discoveries to pave the way for new avenues in the treatment of diabetes and related metabolic disorders. As she continues to push the boundaries of scientific understanding, Loraine's contributions will undoubtedly leave a lasting impact on the health and well-being of many.